Sign in or subscribe to read the full post and get every Atlas trade in your inbox.

When Zacks runs two separate pieces in the same cycle asking whether PRDO is undervalued, it's worth paying attention. Perdoceo Education Corp is sitting at $33.46, trading at 12.2x earnings, with a 2

The pattern day trading rule is dead, and Webull just told CNBC it "changed the outlook" for their entire business. That's not marketing spin — that's a structural tailwind landing on a stock trading

IQVIA just won an AI Breakthrough Award, got crowned the No. 1 pharma tech provider by Everest Group, and its stock is up 42% in three months. So naturally, we're selling a put $10 below the current p

Brinker International has been one of the more quietly impressive stories in consumer cyclical this year — and the stock is now sitting 57% above its 200-day moving average. That kind of momentum tend

Hesai Group doesn't get the press that the U.S. AV names do, but it's quietly one of the more interesting setups in the autonomous driving supply chain. The Chinese LiDAR manufacturer has a 14.9% prof

Progressive Corp trades at a beta of 0.26. Let that sink in. While the broader market has been doing its usual drama-club impression, PGR has been quietly compounding, writing policies, and making Ber

Pool Corporation isn't a sexy ticker. It distributes swimming pool supplies — chemicals, equipment, plumbing parts — to contractors across North America. But POOL has quietly been one of the better co

Corbus Pharmaceuticals has spent most of 2026 quietly doing the work. Last patient, last visit in CANYON-1 for their obesity candidate CRB-913. FDA clearance to kick off TEMPO-1 — a registrational stu

HCA Healthcare is generating headlines for all the wrong reasons — labor unrest, a securities investigation, a stock sitting well below its 200-day moving average. And yet the trade setup here is quie
NewtekOne trades at 5.9x earnings and yields nearly 6% — numbers that either mean deep value or a value trap. We're betting on the former with a short put at $12.50 expiring September 18, collecting $
Atlas Portfolio results shown on this page are produced in a simulation environment using EOD market data and contract pricing. They are not records of trades placed in a brokerage account or executed with real capital, and individual results would vary based on fills, commissions, slippage, and account size. Tiblio is a software platform for finding and executing options trade ideas. We are not a registered investment advisor or broker-dealer. Nothing on this page is financial advice. Options trading involves substantial risk of loss. Past or simulated performance does not guarantee future results.